✦ LIBER ✦

TCT-203 12-months Clinical Outcomes of Bioresorbable everolimus-eluting Vascular Scaffold for the Treatment of Chronic Total Occlusions: CTO ABSORB pilot study

✍ Scribed by Vaquerizo, Beatriz; Barros, Antonio; Pujadas, Sandra; Bajo, Ester; ESTRADA-YÁNEZ, DARLENE; Miranda-Guardiola, Faustino; Jimenez, Marcelo; Arzamendi, Dabit; Garcia-Picart, Juan; Cinca, Juan; Serra, Antonio

Book ID: 126547724
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 73 KB
Volume: 64
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2014.07.244

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TCT-40 Incidence and Acute Clinical Outc

TCT-40 Incidence and Acute Clinical Outcomes of Small Side Branch Occlusion After Implantation of Everolimus-eluting Bioresorbable Vascular Scaffold in the ABSORB-EXTEND Single-arm Trial

✍ Takashi Muramatsu; Yoshinobu Onuma; Hector M. Garcia-Garcia; Vasim Farooq; Marie 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 75 KB

TCT-37: ABSORB Cohort B Trial: 9 Months

TCT-37: ABSORB Cohort B Trial: 9 Months Clinical Results of the Evaluation of the Bioresorbable Everolimus-Eluting Vascular Scaffold (BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 146 KB